We have undertaken a prospective, randomized study to determine the incidence of postoperative nausea and vomiting during intensive care stay after cardiac surgery, and to study the effect of addition of droperidol to an infusion of morphine used for postoperative analgesia. Data from 398 patients were examined. The use of droperidol reduced complaints of nausea from 92 of 198 (46.5%) to 46 of 200 (23%) and episodes of retching or vomiting from 73 of 198 (36.9%) to 44 of 200 (22%). The number of patients requiring rescue antiemetic medication was also reduced significantly from 100 of 198 (50.5%) of those who did not receive droperidol to 44 of 200 (22%) of those given droperidol. Mean duration of intubation was 4.9 h and was unaffected by the use of droperidol. Droperidol had no effect on mean length of stay in the recovery unit. (Br.
Nausea and vomiting are common and distressing symptoms during recovery from anaesthesia and surgery. Studies of postoperative nausea and vomiting (PONV) have concentrated frequently on women undergoing gynaecological procedures and there is little information on the incidence or management of nausea and vomiting after cardiac surgery.
The aim of this study was to assess the incidence of nausea and vomiting in the first 24 h after cardiac surgery, in a unit in which early tracheal extubation is usual 1 . In addition, we wished to ascertain if the addition of droperidol to a continuous infusion of morphine would reduce nausea and vomiting without causing excessive sedation and thereby increase the duration of tracheal intubation and postoperative mechanical ventilation.
Patients and methods
After obtaining approval from the hospital Ethics Committee, we collected data on 442 patients undergoing elective or urgent open heart surgery. Premedication with papaveretum or morphine (10-20 mg) together with hyoscine 0.2-0.4 mg was given i.m. approximately 1 h before surgery. All patients received supplementary oxygen from the time of premedication. After insertion of i.v. and arterial cannulae, anaesthesia was induced with fentanyl 10-15 g kg 91 and etomidate 5-10 mg. Neuromuscular block was produced with pancuronium and, after tracheal intubation, anaesthesia was maintained with halothane in oxygen and air until the start of cardiopulmonary bypass. Ventilation was adjusted to produce normocapnia. Anaesthesia during bypass was provided by continuous infusion of propofol 6 mg kg 91 h 91 and after bypass by halothane in oxygen and air. At the end of surgery, neuromuscular block was antagonized with neostigmine and glycopyrronium and the patient transferred to the cardiac recovery unit (CRU).
After age and sex stratification, patients were allocated randomly to one of two groups: group A received an infusion of morphine 60 mg in saline 58 ml to which was added droperidol 10 mg; group B received a similar infusion of morphine to which 2 ml of normal saline were added. Both patients and nurses caring for them were unaware of the nature of the additive.
After reconnection of monitoring cannulae and initial stabilization in the CRU, the infusion of morphine was commenced. Patients with a body weight greater than 60 kg received an initial bolus dose of morphine 4 mg followed by an initial infusion of 2 mg h 91 , with boluses of 2 mg as indicated. Patients weighing less than 60 kg received an initial dose of 2 mg with an infusion of 1 mg h 91 and a bolus of 1 mg. The infusion rate was adjusted at the discretion of the attending nurse. If analgesia was inadequate diclofenac 50-100 mg, by suppository, was given, provided there were no contraindications to its use. Patients' lungs were ventilated mechanically until the following criteria for a trial of spontaneous respiration and extubation were met: (1) up to 7.5 kPa) was not a contraindication to extubation. After tracheal extubation patients were seated upright and allowed to breathe oxygen-enriched air. If the patient did not meet the criteria for tracheal extubation and required sedation to tolerate intubation and ventilation, an infusion of propofol 1-4 mg kg 91 h 91 was commenced until another trial of spontaneous breathing was performed at the discretion of the nursing staff.
Data collected included patient age, sex, height, weight and operation. When patients were awake, the presence of nausea was ascertained by hourly questioning. Retching or vomiting and need for other antiemetics were noted. As retching is similar to vomiting in all aspects except the production of vomitus, we elected to examine both retching and vomiting together. A "vomiter" was thus any patient who had at least one episode of retching or vomiting. Rescue medication of metoclopramide 10 mg, by slow i.v. injection, was prescribed for all patients and given as required by the nurse caring for the patient. Observations were continued until patients were discharged to the ward on the following day. Duration of intubation, total cumulative dose of morphine administered in the recovery unit, and duration of stay within the recovery area were also noted.
Data were analysed using an unpaired t test for patient data and chi-square analysis for comparison of events between groups. P:0.05 was considered significant.
Results
Complete data were collected for 398 patients. Data were discarded from 21 patients who had a second anaesthetic for repeat sternotomy or died in the recovery unit, or whose trachea remained intubated for the whole of the first 24 h, and from 20 patients for whom data were incomplete. Data from three other patients who were receiving dialysis for chronic renal failure were also discarded. Age, body weight and sex distribution are shown in table 1. There were no significant differences between the two groups. Operative details are shown in table 2 and were similar for the two groups.
Mean stay in the CRU and therefore number of hours recorded was 21.9 h and was not significantly different between the two groups. Mean morphine consumption during this time was 29 (SD 11.3) mg, with maximum consumption of 60 mg and minimum consumption of 6 mg. There was no correlation between body mass index (weight (kg)/height (m) 2 ) and morphine consumption, or between age and morphine consumption. Mean duration of intubation was 4.9 (4.3) h and was not significantly different between the two groups (table 3).
There were highly significant differences in the incidence of PONV between the two groups. given droperidol (table 3) . There was no correlation between body mass index and propensity for nausea or vomiting. When data were examined to investigate the influence of sex on nausea and vomiting, it became apparent that women were significantly more likely than men to suffer nausea, retching and vomiting (table 4). Although droperidol was effective in significantly decreasing retching and vomiting in women, it did not significantly reduce the incidence of nausea. This last observation may be related to the relatively small number of women in the sample, reducing the power of the measurement.
Data were also examined to assess the effect of age on PONV (table 5) . There was a statistically significant reduction in the incidence of PONV in patients more than 80 yr of age.
Discussion
It is important to minimize vomiting and retching after surgery to avoid potential cardiovascular complications and to improve patient comfort and assist in rapid recovery. The latter is of particular importance with increasing financial pressure and the drive to reduce inpatient stay 2 . While there was no significant difference in the length of stay in the CRU between vomiters and non-vomiters, this is not surprising as PONV is unlikely to be a problem requiring an increase in the length of high dependency nursing.
Until about 6 yr ago it was our standard practice to sedate patients after cardiac surgery and to ventilate the lungs for a period of 12-16 h after operation. Nausea and vomiting were not perceived as particular problems with this regimen, and it is possible that a lengthy period of sedation and artificial ventilation reduced the incidence of postoperative emesis. More recently, we have tended to extubate the trachea much earlier after surgery 3 and have become increasingly aware of the problem of PONV. Our study has shown that using a moderate dose of fentanyl, and extubating the trachea within the first 6-8 h after cardiac surgery, the incidence of nausea was approximately 37% and that of postoperative retching or vomiting approximately 47%, despite the use of hyoscine as premedication. The overall incidence of nausea and vomiting was therefore of a similar order to that after other types of major surgery 4 . In common with Myles and colleagues 5 , we have found that many of our patients are unable to use patient-controlled analgesia effectively in the first 24 h after cardiac surgery, and we therefore rely on a nurse-controlled regimen for the early postoperative period. Addition of droperidol to infusion of morphine reduced significantly the incidence of nausea and approximately halved the incidence of retching and vomiting. While it has been argued that prophylactic administration of antiemetics is unjustified 6 , in view of the high incidence of PONV and its potential deleterious effects after cardiac surgery, the prophylactic use of droperidol has now become part of our standard practice.
Droperidol is a neuroleptic agent with potent dopamine receptor antagonist properties and is an effective antiemetic in a variety of doses. Bolus doses are contraindicated after cardiac surgery as its ␣ blocking actions may cause hypotension. Low doses of droperidol have been shown to effectively reduce the incidence of postoperative nausea and vomiting when mixed with morphine and used for patientcontrolled analgesia [7] [8] [9] and it has been suggested as the agent of choice for prophylaxis 10 . Newer 5-HT3 antagonist drugs have not been shown to be significantly more effective 11 and are considerably more expensive.
Droperidol has a long duration of action and is associated with sedation and extrapyramidal reactions. When used in combination with morphine for patient-controlled analgesia, addition of droperidol appears to cause significantly greater sedation 12 13 , although in single low doses it has been shown to have no effect on recovery time 14 . We were concerned that routine use of droperidol might prolong the duration of intubation after cardiac surgery. Although we did not measure sedation scores, we found that the use of droperidol had no effect on duration of postoperative intubation, nor did it prolong patient stay in the CRU. The mean dose of droperidol was approximately 5 mg during a mean stay of 21.9 h, that is approximately 0.23 mg h
91
. While we would not dispute that there may have been some increase in sedation which was not measured, the sedative effects were not clinically important.
In common with most other studies of vomiting, we found that both nausea and vomiting were associated significantly with female sex. Lerman 15 has suggested that the incidence of PONV is approximately 2-3 times greater in women than in men. In this study, PONV appeared to be about 1.5-2 times more common in women.
When the effect of age on the incidence of nausea and vomiting was examined, although the number of patients aged more than 80 yr was small, octogenarians suffered significantly less PONV than younger patients. At the lower end of the age range there were only three patients aged less than 40 yr but all three suffered nausea and two vomited. Thus it appears that age does have some effect on the propensity for PONV after heart surgery.
While obesity has been reported to increase PONV 4 , in contrast with other studies 17 , we did not show any correlation between body mass index and nausea and vomiting.
In summary, we found that the incidence of PONV after cardiac surgery was similar to that after other major surgical procedures. We also observed that the addition of droperidol to a continuous infusion of morphine significantly reduced the incidence of nausea and vomiting after cardiac surgery without prolonging the duration of intubation or postoperative intensive care stay.
